Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-081714

Chief Medical Officer gave up 1,395 shares (to pay taxes)

  • Chief Medical Officer acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRAF FINCKENSTEIN FRIEDRICH · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-14 Exercise or conversion : show line 1 in the form +2,813 32,348 D
2023-07-14 Shares withheld for taxes : show line 2 in the form −1,395 $7.76 $10,825 30,953 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,813 16,877 D
Loading xslF345X05/tm2321428-2_4seq1.xml…